Carlos Jericó Selected Research

Carlos Jericó Research Topics

7	COVID-19 10/2022 - 01/2021
6	Infections 10/2022 - 12/2017
5	Anemia 01/2021 - 01/2016
2	Inflammation (Inflammations) 01/2021 - 08/2019
2	Iron Deficiencies 08/2019 - 01/2016
2	Hypertension (High Blood Pressure) 11/2005 - 01/2005
1	Ischemic Stroke 01/2021
1	Neoplasms (Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2020
1	Morbid Obesity 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Carotid Artery Diseases 03/2006
1	Atherosclerosis 03/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2005
1	Hypertriglyceridemia 01/2005
1	Abdominal Obesity 01/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2004

4	ABO Blood-Group SystemIBA 10/2022 - 01/2022
4	IronIBA 01/2020 - 01/2016
3	Blood Group Antigens (Blood Groups)IBA 10/2022 - 05/2022
2	HDL CholesterolIBA 01/2021 - 01/2005
2	Hemoglobins (Hemoglobin)IBA 08/2019 - 12/2017
1	AntibodiesIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	phytobacteriomycin (PBM)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	LipidsIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	HematinicsIBA 08/2019
1	Stavudine (Zerit)FDA LinkGeneric 01/2005
1	Glucose (Dextrose)FDA LinkGeneric 01/2005
1	Ritonavir (Norvir)FDA Link 01/2005
1	CholesterolIBA 01/2005
1	Lopinavir FDA Link 01/2005
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2005

3	Therapeutics 01/2022 - 03/2006
3	Highly Active Antiretroviral Therapy (HAART) 03/2006 - 03/2004
2	Erythrocyte Transfusion 01/2020 - 08/2019
2	Length of Stay 08/2019 - 12/2017
1	Gastrectomy 01/2021
1	Secondary Prevention 01/2021
1	Bariatric Surgery 01/2016